. "Lisa C Holthof" . "Marloes E C Broekmans" . . "Berris van Kessel" . "Francois Gaudet" . . . "wetenschappelijk artikel"@nl . "Preclinical Activity of JNJ-7957, a Novel BCMA\u00D7CD3 Bispecific Antibody for the Treatment of Multiple Myeloma, Is Potentiated by Daratumumab"@en . "Preclinical Activity of JNJ-7957, a Novel BCMA\u00D7CD3 Bispecific Antibody for the Treatment of Multiple Myeloma, Is Potentiated by Daratumumab"@nl . "10.1158/1078-0432.CCR-19-2299" . "article scientifique publi\u00E9 en 2020"@fr . . . "\u0563\u056B\u057F\u0561\u056F\u0561\u0576 \u0570\u0578\u0564\u057E\u0561\u056E \u0570\u0580\u0561\u057F\u0561\u0580\u0561\u056F\u057E\u0561\u056E 2020 \u0569\u057E\u0561\u056F\u0561\u0576\u056B \u0570\u0578\u0582\u0576\u057E\u0561\u0580\u056B 22-\u056B\u0576"@hy . "Preclinical Activity of JNJ-7957, a Novel BCMA\u00D7CD3 Bispecific Antibody for the Treatment of Multiple Myeloma, Is Potentiated by Daratumumab"@en . "Rengasamy Boominathan" . "Preclinical Activity of JNJ-7957, a Novel BCMA\u00D7CD3 Bispecific Antibody for the Treatment of Multiple Myeloma, Is Potentiated by Daratumumab"@en . "art\u00EDculu cient\u00EDficu espubliz\u00E1u en xineru de 2020"@ast . . "Jhon A Marin Soto" . "scientific article published on 22 January 2020"@en . . . . . "Preclinical Activity of JNJ-7957, a Novel BCMA\u00D7CD3 Bispecific Antibody for the Treatment of Multiple Myeloma, Is Potentiated by Daratumumab"@nl . "Bhavesh Vaidya" . "31969333" . "Christie P M Verkleij" . . "Jocelyn Sendecki" . . . . . . "Amy Axel" . . . . . "2020-01-22T00:00:00Z"^^ . . "\u043D\u0430\u0443\u043A\u043E\u0432\u0430 \u0441\u0442\u0430\u0442\u0442\u044F, \u043E\u043F\u0443\u0431\u043B\u0456\u043A\u043E\u0432\u0430\u043D\u0430 22 \u0441\u0456\u0447\u043D\u044F 2020"@uk . . . "Martijn W Heymans" . "Preclinical Activity of JNJ-7957, a Novel BCMA\u00D7CD3 Bispecific Antibody for the Treatment of Multiple Myeloma, Is Potentiated by Daratumumab"@en . "Kodandaram Pillarisetti" . . . . . . . . . "Preclinical Activity of JNJ-7957, a Novel BCMA\u00D7CD3 Bispecific Antibody for the Treatment of Multiple Myeloma, Is Potentiated by Daratumumab"@nl . .